An elixir of breast milk and New Zealand honey is the next big fountain of youth for nutraceuticals seller Bioxyne.

The dietary supplements maker says it has just won the nod to sell a honey, colostrum and milk powder formula into Malaysia — and its seeking an import licence for China.

The first shipment of 10,000 cans is expected before the end of June.

The shares jumped 13 per cent to 11c in Monday morning trade — but closed down 6 per cent at 9.1c.

Colostrum is “a thick, sticky, yellowish mammary secretion that all mammals provide to their newborns during the first 24–48 hours after delivery”, according to a research review called Health Benefits of Bovine Colostrum in Children and Adults released in December last year.

In recent years colostrum has become popular as a supplement for adults under the proviso that if it makes babies grow, it must also be good for their parents.

The research review suggested trials need to be held in order to find out whether the health claims hold up.

Bioxyne shares (ASX:BXN) over the past six months.
Bioxyne shares (ASX:BXN) over the past six months.

Bioxyne (ASX:BXN) also now makes the claim that it’s not just Manuka honey that is good for you, but New Zealand honey generally.

A number of ASX small caps are working on Manuka Honey products.

“Scientists are discovering that natural New Zealand honey has wide ranging health benefits,” Bioxyne told investors.

“New Zealand honey, gathered from the pristine and clean environment of New Zealand contains antioxidants, vitamins, minerals, amino acids and enzymes that add to the immune system and general health and wellbeing.”